215317-14-9 Usage
Uses
Used in Organic Chemistry:
(R)-3-(2-phenylethyl)-3-[(4-phenylphenoxy)methoxy]hexanal is used as a building block for the synthesis of more complex organic molecules due to its unique structural features and the potential for chemical reactions at various points along the molecule.
Used in Pharmaceutical Industry:
(R)-3-(2-phenylethyl)-3-[(4-phenylphenoxy)methoxy]hexanal is used as a precursor in the development of new pharmaceutical compounds, leveraging its complex structure and potential for interactions with biological systems to create novel drugs with specific therapeutic properties.
Used in Material Sciences:
(R)-3-(2-phenylethyl)-3-[(4-phenylphenoxy)methoxy]hexanal is used as a component in the creation of advanced materials, taking advantage of its structural complexity and the possibility of tailoring its properties through chemical modifications for various applications, such as in the development of new polymers or coatings with specific characteristics.
Check Digit Verification of cas no
The CAS Registry Mumber 215317-14-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,5,3,1 and 7 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 215317-14:
(8*2)+(7*1)+(6*5)+(5*3)+(4*1)+(3*7)+(2*1)+(1*4)=99
99 % 10 = 9
So 215317-14-9 is a valid CAS Registry Number.
215317-14-9Relevant academic research and scientific papers
Process to produce a protease inhibitor
-
, (2008/06/13)
Disclosed is a novel process and novel intermediates to prepare [R-(R*,R*)]-N-[3-[1-[5,6-dihydro-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-2H-pyran-3-yl]propyl]phenyl]-5-(trifluoromethyl)-2-pyridinesulfonamide (XIX) which is a protease inhibitor useful in treating humans infected with the HIV virus.
A convergent, scalable synthesis of HIV protease inhibitor PNU-140690
Fors, Kristina S.,Gage, James R.,Heier, Richard F.,Kelly, Robert G.,Perrault, William R.,Wicnienski, Nancy
, p. 7348 - 7356 (2007/10/03)
PNU-140690, an inhibitor of the HIV protease enzyme undergoing clinical evaluation as a chemotherapeutic agent for treatment of AIDS, was synthesized by a convergent approach amenable to large-scale preparation in a pilot plant environment. The key step is the aldol addition of nitroaromatic ester (+)-8 to aldehyde 19e. The two stereocenters present in the target molecule were each set independently by resolution of enantiomers. Intermediates along the synthetic routes were chosen to maximize opportunities for isolation and purification by crystallization.
